Reactions Weekly

, Volume 1134, Issue 1, pp 2–2 | Cite as

Avosentan stopped in it’s ascent to diabetic nephropathies

Media release
  • 8 Downloads

Keywords

Placebo Diabetes Mellitus Creatinine Serum Creatinine Diabetic Nephropathy 

REFERENCE

  1. 1.
    Speedel.Speedel Stops Current Spp301 Phase III Trial in Diabetic Kidney Disease in the Interests of Patient Safety. Media Release: 19 Dec 2006. Available from: URL: http://www.speedel.com

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations